-

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

Thomas brings over a decade of PE and investment banking experience to lead origination and business development for the firm, portfolio companies

NASHVILLE, Tenn.--(BUSINESS WIRE)--Iron Path Capital (Iron Path), a private equity firm focused on healthcare and specialty industrials, today announced the appointment of Ian Thomas as Managing Director – Head of Business Development to lead origination and business development for the firm and its portfolio companies. His experience in both private equity and investment banking provides a wide expertise to drive Iron Path’s strategic growth and value-add capabilities.

“Ian’s track record makes him a valuable addition to our team, and he will play a key role in our continued growth, momentum and portfolio company success,” said Scott Mraz, co-founder and Managing Partner of Iron Path.

Thomas brings more than 13 years of experience and has executed multiple transactions in his career. Prior to joining Iron Path, he was the founder of Aliri Capital, a lower-middle-market independent sponsor that focused on investing in family-owned services businesses with $2 million to $15 million of EBITDA. Previously, Thomas was a Managing Director at Sole Source Capital in Dallas, a $555 million middle-market industrial buyout fund. As Head of Origination, he managed a team responsible for building relationships with intermediaries and business owners to source proprietary investment opportunities for the firm.

Earlier in his career, Thomas was a director at Harris Williams, a middle-market investment bank, where he executed sell-side and buy-side deals across numerous sub-sectors within specialty industrials including industrial automation, value-added distribution, and tech enabled services, among others.

“Iron Path has an exceptional team delivering differentiation in the market, and I look forward to our work together,” said Thomas. “I’m eager to help shape the future and deliver value to our investors, founders, and our portfolio companies.”

Thomas is a graduate of the Darden School of Business at the University of Virginia and earned his undergraduate degree from the University of North Carolina at Chapel Hill.

About Iron Path Capital

Iron Path Capital is an operationally focused private equity firm focused on lower-middle-market investments across the healthcare and specialty industrial sectors. With offices in Nashville, TN and Charlottesville, VA, Iron Path Capital supports its partners with capital, operating expertise, business development, and industry relationships to achieve significant scale. Iron Path Capital selects companies with stable cash flows, superior management teams, strong performance trajectories, and multiple vectors for growth, both organic and through consolidation.

Visit ironpathcapital.com for more information.

Contacts

Iron Path Capital Media Contact
Media@ironpathcapital.com

Iron Path Capital

Details
Headquarters: Nashville & Charlottsville, Tennessee & Virginia
CEO: Rob Reistetter
Employees: 8
Organization: PRI

Release Versions

Contacts

Iron Path Capital Media Contact
Media@ironpathcapital.com

Social Media Profiles
More News From Iron Path Capital

Iron Path Capital Announces Partnership with Gougeon Brothers, Inc. as First Investment in Advanced Materials Platform

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Iron Path Capital, a private equity firm focused on healthcare and specialty industrials, today announced a growth partnership with Gougeon Brothers, Inc., a leading epoxy manufacturer in the composites and marine end markets. “We are delighted to partner with the Gougeon management team to develop and grow their market-leading WEST SYSTEM®, PRO-SET®, and Entropy Resins® epoxy resin systems for making and repairing composite structures,” said Ted Clark, Pa...

Iron Path Capital Names Jake Fitzgerald as New CEO of PureTech Scientific

NASHVILLE, Tenn. & BELLE, W. Va.--(BUSINESS WIRE)--Iron Path Capital (Iron Path), a private equity firm focused on healthcare and specialty industrials, today announced the appointment of industry veteran Jake Fitzgerald as Chief Executive Officer of PureTech Scientific LLC (PureTech), a global leader in glycolic acid synthesis and technology. PureTech was founded by Iron Path after acquiring the Glycolic Acid business from The Chemours Company last August. Fitzgerald most recently served as Pr...

Iron Path Capital Closes Fund I, Exceeds Target at $273 Million

CHARLOTTESVILLE, Va. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Iron Path Capital (“Iron Path” or “IPC”), an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, today announced the final closing of Iron Path Capital Fund I (“Fund I”), exceeding the $250 million target with total commitments of $273 million. The Fund I limited partners consist of a diverse group of global investors including leading endowments, fund of funds, institutional investors...
Back to Newsroom